Governance
This project is supported by grant funding from the European and Developing Countries Trials Partnership, EDCTP2.
The MoxiMultiDoseMod project is being conducted by a consortium coordinated by the Luxembourg Institute of Health (LIH) and involving 10 participant organisations. In addition to participant contributions, the project is receiving scientific advice and technical support from the WHO Special Programme for Research and Training in Tropical Diseases (WHO-TDR).
To ensure appropriate governance of the project, two committees have been implemented to oversee and make strategic decisions for the program beyond the financial and technical reporting requirements to EDCTP.
Executive Committee
The Executive Committee is convened to supervise the overall conduct of the MoxiMultiDoseMod project. The Committee formulates proposals and make decisions on the project including changes to membership of the consortium, project activities, funding allocation and communication and dissemination of tools, data and information from the project.
The following organisations are represented on the Committee:
Communaute Evangelique au Centre de l’Afrique (CECA-20)
The CECA-20, the Evangelical Community in the Center of Africa, which is a non-profit organization, is the 20th community of the Church of Christ in Congo (ECC) in the Democratic Republic of Congo. It is of Protestant worship. It was founded by the Missionary Society of Africa Inland Mission (AIM), which began the work of evangelization in 1912 in the Appii / Kasengu region of the Province of Ituri.
It is headquartered is in Bunia, in the Ituri Province. Today, CECA, has several parishes located in the Oriental Province, in North and South Provinces of North and South Kivu, in the Upper Katanga Province, in the Kwango Province, and an ecclesial representation in Kinshasa. Nowadays, CECA is headed by the Reverend Agupio Amanio Goli, who is the President and Legal Representative. As part of its activities, CECA-20 has a social development department that aims to bring support to its members disseminated within several provinces in the areas of (1) education and training, (2) health, (3) agriculture and fishing, (4) communication.
Nominated Member and Chair of the Committee: Dr Tony Ukety
Medicines Development for Global Health
Medicines Development for Global Health (MDGH) is an independent biopharmaceutical company dedicated to the development of affordable medicines and vaccines for the people who need them most. MDGH is a not-for-profit company that uses all funds in excess of running costs to develop medicines and vaccines that address important unmet medical needs but may have limited commercial opportunities.
Nominated Member: Ms Sally Kinrade
University of Health and Allied Sciences (UHAS), Ghana
The University of Health and Allied Sciences, Ho (UHAS) was established by an Act of Parliament (Act 828 in December, 2011) and envisioned to become a pre-eminent research and practically oriented health educational institution dedicated to community service. The main campus including the central administration is in Ho. A second campus is located in Hohoe. UHAS is the first public university to be established in the Volta Region of Ghana and is so far the only state university wholly dedicated to the training of healthcare professionals in Ghana.
Nominated member: Dr Nicholas Opuku.
World Health Organization - Special Programme for Research and Training in Tropical Diseases
(WHO-TDR)
TDR, the Special Programme for Research and Training in Tropical Diseases, is a global programme of scientific collaboration that helps facilitate, support and influence efforts to combat diseases of poverty. It is co-sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the World Bank and World Health Organization (WHO). Its mission is to ‘To support effective and innovative global health research, through strengthening the research capacity of disease-affected countries, and promoting the translation of evidence into interventions that reduce the burden of infectious diseases and build resilience in the most vulnerable populations.’
Nominated Member: Dr Annette Kuesel.
Imperial College of Science Technology and Medicine, London (ICL)
Imperial College London is a world top ten university with an international reputation for excellence in teaching and research based in the United Kingdom. Imperial is committed to developing the next generation of researchers, scientists and academics through collaboration across disciplines. Imperial brings together intersecting disciplines, industries and sectors across four major areas to further our understanding of the natural world, solve major engineering problems, lead the data science revolution and improve health and well-being.
Nominated Member: Prof. Maria-Gloria Basáñez
Erasmus University Medical Center Rotterdam (Department of Public Health)
Erasmus MC is a single organisation that encompasses a full spectrum of clinical services, including those provided by two specialist units operating under the Erasmus MC umbrella: Erasmus MC Sophia Children’s Hospital and Erasmus MC Cancer Institute. its mission is to achieve a healthy population and pursuing excellence in healthcare through research and teaching.
Nominated Member: Prof. Sake de Vlas
Luxembourg Institute of Health (LIH)
The Luxembourg Institute of Health (LIH) is a public research organisation at the forefront of biomedical sciences. LIH aims to perform research that transcends the boundaries of individual diseases and that can be tangibly applied in the clinical practice to address unmet needs, thus positively affecting health outcomes for patients. With its strong expertise in population health, oncology, infection and immunity as well as storage and handling of biological samples, LIH investigates disease mechanisms to develop new diagnostics, innovative therapies and effective tools for personalised medicine.
Nominated Member: Dr Michel Vaillant
Data and Safety Monitoring Board
Dr. Paul-Samson Lusamba-Dikassa
Board chair
Former Director of African Programme for Onchocerciasis Control
Former Director of Programme Management, World Health Organization African region
Currently Prof of Public Health at Public Health School of Kinshasa, University of Kinshasa & Member of Onchocerciasis Elimination Committee Democratic Republic of Congo
A/Prof. Andrew Steer
Board member
Paediatric Infectious Diseases Physician
Murdoch Children’s Research Institute / Royal Children’s Hospital / University of Melbourne
Low-income and middle-income countries research
Dr Michel Boussinesq
Board member
Director of Research, Institut de Recherche pour le Developpment / University of Montpellier
Onchocerciasis research expertise
Dr Eric Kanza
Board member
Ophthalmologist
Vice-Director, North Kivu Provincial Hospital, Goma
Principal Investigator of Phase 3 study in Democratic Republic of Congo
Prof. Alex Y. Debrah
Board Member
Dean, Faculty of Allied Health Sciences, Kwame Nkrumah University of Sciences and Technology, Ghana
Molecular epidemiology of parasitic infections, immunogenetics and clinical trials research expertise
Prof. Stephen Senn
Biostatistician
Consultant Statistician
Honorary Professor of Medical Statistics, ScHARR, University of Sheffield